【结 构 式】 |
【药物名称】CT-052923 【化学名称】N-(1,3-Benzodioxol-5-ylmethyl)-4-(6,7-dimethoxyquinazolin- 4-yl)piperazine-1-carbothioamide 【CA登记号】 【 分 子 式 】C23H25N5O4S 【 分 子 量 】467.5508 |
【开发单位】COR Therapeutics; Kyowa Hakko 【药理作用】ONCOLYTIC DRUGS, INHIBITORS OF SIGNAL TRANSDUCTION PATHWAYS |
合成路线1
The title thiourea derivative was prepared by condensation of 6,7-dimethoxy-4-piperazinylquinazoline (I) with 1,3-benzodioxol-5-ylmethyl isothiocyanate (II) in refluxing ethanol.
【1】 Matsuno, K.; et al.; Potent and selective inhibitors of PDGF receptor phosphorylation. 2. Synthesis, structure activity relationship, improvement of aqueous solubility, and biological effects of 4-[4-(N-substituted (thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline deri. J Med Chem 2002, 45, 20, 4513. |
【2】 Matsuno, K.; Ichimura, M.; Nomoto, Y.; Fujiwara, S.; Ide, S.; Tsukuda, E.; Irie, J.; Oda, S. (Kyowa Hakko Kogyo Co., Ltd.); Nitrogenous heterocyclic cpds. EP 0882717; WO 9814431 . |
Extended Information